Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01142427 · ClinicalTrials.gov registry record
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 17,463
- Enrollment target
NCT01142427: Completed study, sponsored by Children's Oncology Group.
NCT01142427 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 17,463 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01142427 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 17,463 participants
- Enrollment target
Study Summary
This research trial studies a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia. Gathering health information about patients with acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment.
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Cytology Specimen Collection Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17,463 participants |
| Start Date | 2010-08-09 |
| Est. Completion | 2023-09-30 |
What the finished NCT01142427 record still lists
NCT01142427 is an observational study that tracks outcomes without assigning an intervention. Its 17,463 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT01142427 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01142427 about?
NCT01142427 is a clinical study titled "Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia". This research trial studies a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia. Gathering health information about patients with acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment.
What is the current status of trial NCT01142427?
This trial is currently completed. The enrollment target is 17,463 participants. The study started on 2010-08-09. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT01142427?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Cytology Specimen Collection Procedure (OTHER).
Who is sponsoring clinical trial NCT01142427?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06272110 · 17,500 participants
Promoting Equitable Access to Language Services in Health and Human Services
- NCT07290361 · 17,587 participants · NA
Stratified Targeted Engagement From Primary Care to Physical Therapy (STEPPT)
- NCT06245187 · 17,198 participants
Get With the Guidelines Atrial Fibrillation Registry
- NCT07108660 · 17,800 participants · NA
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI